Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01238484 · ClinicalTrials.gov registry record · NA
Ankle Equinus Contracture Treated With Dynamic Splinting
A NA study, sponsored by Dynasplint Systems.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01238484 is a NA study that was terminated before completion, run by Dynasplint Systems. The registered enrollment target is 15 participants.
The verdict
NCT01238484, a NA study, was terminated before completion, sponsored by Dynasplint Systems.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the Ankle Dorsiflexion Dynasplint System (DS) is effective in treating contracture for patients with Ankle Equinus secondary to diabetes mellitus.
Interventions
- OTHER Standard of care
- DEVICE Dynasplint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-08 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01238484
The ClinicalTrials.gov registry entry for NCT01238484 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dynasplint Systems, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of care is the first listed.
NCT01238484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01238484 about?
NCT01238484 is a clinical study titled "Ankle Equinus Contracture Treated With Dynamic Splinting". The purpose of this study is to determine if the Ankle Dorsiflexion Dynasplint System (DS) is effective in treating contracture for patients with Ankle Equinus secondary to diabetes mellitus.
What is the current status of trial NCT01238484?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2010-08. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01238484?
The interventions under investigation include: Standard of care (OTHER), Dynasplint (DEVICE).
Who is sponsoring clinical trial NCT01238484?
This trial is sponsored by Dynasplint Systems, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.